# Comparing the Safety and Efficacy of Paclitaxel Controlled Release Balloon Catheter in the Treatment of In-stent Restenosis of Coronary Artery Lesion With Paclitaxel Release Coronary Balloon Catheter

> **NCT02891018** · PHASE3 · UNKNOWN · sponsor: **Shandong Branden Med.Device Co.,Ltd** · enrollment: 260 (estimated)

## Conditions studied

- In-stent Restenosis

## Interventions

- **DEVICE:** paclitaxel controlled release balloon catheter Vasoguard TM
- **DEVICE:** paclitaxel release coronary balloon catheter SeQuent Please

## Key facts

- **NCT ID:** NCT02891018
- **Lead sponsor:** Shandong Branden Med.Device Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2017-12
- **Final completion:** —
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2016-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02891018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02891018, "Comparing the Safety and Efficacy of Paclitaxel Controlled Release Balloon Catheter in the Treatment of In-stent Restenosis of Coronary Artery Lesion With Paclitaxel Release Coronary Balloon Catheter". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02891018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*